SOCS3 and chronic myelogenous leukemia, BCR-ABL1 positive: SOCS3 was down-regulated in CML cell lines and most of BMNCs from CML patients, and the expression level of SOCS3 was associated with the inhibition of cell proliferation and drug resistance of CML cells.